Stay updated with breaking news from Therapeutic Development Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stock analysts at StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Performance NAVB stock opened at $0.05 on Friday. The firm has a market cap of $5.39 […]
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NYSE NAVB opened at $0.05 on Friday. The company has a market cap of $5.00 million, a PE ratio of -0.17 […]
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance NAVB stock opened at $0.05 on Friday. The company has a market capitalization of $5.00 million, a P/E ratio of -0.17 […]
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report issued on Saturday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance NAVB opened at $0.05 on Friday. The stock has a market capitalization of $5.01 million, a price-to-earnings ratio of -0.17 and a beta of […]
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Tuesday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of Navidea Biopharmaceuticals stock opened at $0.09 on Tuesday. The firm has a market capitalization of $9.32 million, a PE ratio […]